NM_000277.3:c.506G>T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000277.3(PAH):c.506G>T(p.Arg169Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R169S) has been classified as Pathogenic.
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Publications
- phenylketonuriaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
- classic phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- maternal phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild hyperphenylalaninemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PAH | NM_000277.3 | c.506G>T | p.Arg169Leu | missense_variant | Exon 5 of 13 | ENST00000553106.6 | NP_000268.1 | |
| PAH | NM_001354304.2 | c.506G>T | p.Arg169Leu | missense_variant | Exon 6 of 14 | NP_001341233.1 | ||
| PAH | XM_017019370.2 | c.506G>T | p.Arg169Leu | missense_variant | Exon 5 of 7 | XP_016874859.1 | ||
| LOC124902999 | XR_007063428.1 | n.807+1372C>A | intron_variant | Intron 1 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PAH | ENST00000553106.6 | c.506G>T | p.Arg169Leu | missense_variant | Exon 5 of 13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
| PAH | ENST00000549111.5 | n.602G>T | non_coding_transcript_exon_variant | Exon 5 of 6 | 1 | |||||
| PAH | ENST00000307000.7 | c.491G>T | p.Arg164Leu | missense_variant | Exon 6 of 14 | 5 | ENSP00000303500.2 | |||
| PAH | ENST00000551988.5 | n.530+10863G>T | intron_variant | Intron 4 of 4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460210Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726554 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:3
Variant summary: PAH c.506G>T (p.Arg169Leu) results in a non-conservative amino acid change located in the Aromatic amino acid hydroxylase, C-terminal (IPR019774) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250586 control chromosomes. c.506G>T has been reported in the literature in individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (Ngiwsara_2021). Additionally another missense (R169H) was internally classified as pathogenic. These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 33677757). ClinVar contains an entry for this variant (Variation ID: 2677436). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg169 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10234516, 18299955, 21147011, 26666653, 28982351). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PAH protein function. This missense change has been observed in individual(s) with hyperphenylalaninemia (PMID: 33677757). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 169 of the PAH protein (p.Arg169Leu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at